References
Bremner CG, Bremner RM. Fifty-eight years of Barrett's oesophagus. Eur Surg 2009;41(1):6–13
Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanism, and endoscopic treatment of Barrett's esophagus. Gastroenterology 2010;138(3):854–69
Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large mulicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006;4(5):566–72
Huo X, Zhang HY, Zhang X, et al. Acid and bile salt induced CDX 2 expression differs in squamous cells from patients with and without Barrett's esophagus. Gastroenterology 2010, Mar. 17, ahead print
Souza R, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009;137(5):1776–84
Rieder F, Biancani P, Harnett K, et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol 2010;298G, ahead print
Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476–80
Chandrasoma P. Definition of norma and reflux-induced anatomy and histology. In: Diagnostic atlas of gastroesophageal reflux disease. A new histology-based method. Elsevier Academic Press; 2007. pp. 112–56
Glickman JN, Spechler SJ, Souza RF, et al. Multilayered epithelium in mucosal biopsy specimens from the gastroesophageal junction region is a histologic marker of gastroesophageal reflux disease. Am J Surg Pathol 2009;33(6):818–25
Philips RW, Frierson HF, Moskaluk CA. CDX 2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 2003;27:1442–7
Rahman F, Kadowaki Y, Ishihara S, et al. Fibroblast-derived HB-EGF promotes CDX 2 expression in esophageal squamous cells. Lab Invest 2010, Mar. 1–16, ahead print
Ayazi S, Hagen J, Chandrasoma P, et al. Esophageal intraepithelial eosinophils in dysphagic patients with gastroesophageal reflux disease. Dig Dis Sci 2010;55:967–72
Liu W, Hahn H, Odze RD, et al. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 2009;104:816–24
Singh S, Bansal A, Puli S, et al. Effect of proton pump inhibitor therapy on inflammatory changes in the gastric cardia (carditis). Dig Dis Sci 2007;52:2178–82
DeMeester SR. Reflux, Barrett's and adenocarcinoma of the esophagus: can we disrupt the pathway? J Gastrointest Surg 2010, ahead print
Arora G, Basra S, Roorda AK, Triadafilopoulos G. Radiofrequency ablation of Barrett's esophagus. Eur Surg 2009;41(1):19–25
Inadomi JM, Somsouk M, Madanick RD, et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009;136(7):2101–14
dos Santos RS, Bizekis C, De Simone M, et al. Radiofrequency ablation and fundoplication for Barrett's esophagus. J Thorac Cardiovasc Surg 2010;139(3):713–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riegler, F. Respond as reflux dials CDX 2. Eur Surg 42, 69–71 (2010). https://doi.org/10.1007/s10353-010-0526-1
Issue Date:
DOI: https://doi.org/10.1007/s10353-010-0526-1